Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Arginase Inhibition on Vascular Endothelial Function in Patients With Type 1 and Type 2 Diabetes

NCT05806502 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05806502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05806502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Arginase Inhibition on Vascular Endothelial Function in Patients With Type 1 and Type 2 Diabetes
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2018
Completion date
April 30, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes